Back
Cabaletta Bio Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
12
CABA
Cabaletta Bio
Last Price:
4.53
Seasonality Move:
150.01%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
57.68
Seasonality Move:
-0.7%
Sell
12
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
- The current Cabaletta Bio [CABA] share price is $4.19. The Score for CABA is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- CABA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.49. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $4.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.49
The current trend is moderately bullish and RARE is experiencing slight selling pressure.
CABA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 35.94 | Sell |
| Chaikin Money Flow: | 67639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.22 - 5.6) | Sell |
| Bollinger Bands (100): | (5.36 - 10.96) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.03 | Buy |
| Relative Strength Index (14 RSI): | 66.85 | Buy |
| Chaikin Money Flow: | -184951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.73 - 58.05) | Buy |
| Bollinger Bands (100): | (39.66 - 52.36) | Buy |
CABA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.2 | Sell |
| 20-day SMA: | 4.99 | Sell |
| 50-day SMA: | 5.87 | Sell |
| 200-day SMA: | 14.1 | Sell |
| 8-day EMA: | 4.29 | Sell |
| 20-day EMA: | 4.77 | Sell |
| 50-day EMA: | 6.01 | Sell |
| 200-day EMA: | 10.95 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.19 | Buy |
| 20-day SMA: | 56.76 | Buy |
| 50-day SMA: | 50.86 | Buy |
| 200-day SMA: | 46.23 | Buy |
| 8-day EMA: | 57.7 | Buy |
| 20-day EMA: | 56.07 | Buy |
| 50-day EMA: | 52.06 | Buy |
| 200-day EMA: | 46.51 | Buy |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.14 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Cabaletta Bio Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||